Lucas Buchanan leads manufacturing and operations, finance and accounting, IT, commercial operations and analytics, health economics and reimbursement, and corporate development efforts for Silk Road Medical. Prior to joining the company full time in 2012, Lucas was an investment professional with The Vertical Group, the founding investor in Silk Road, where he helped lead the company through early development and financing milestones while charting the company’s commercial strategy. Also while at The Vertical Group, Lucas led investments in Atheromed (acquired by Volcano Corporation) and Lutonix (acquired by CR Bard). Lucas has also held various leadership positions in marketing and corporate development/M&A at Impax Laboratories and Medtronic and began his career at Ernst & Young Corporate Finance LLC where he advised healthcare companies on financing and M&A transactions. Lucas holds a B.A. in Economics from Duke University and an M.B.A. in Health Care Management from The Wharton School at the University of Pennsylvania.